
UnitedHealth Group (UNH) Stock Forecast & Price Target
UnitedHealth Group (UNH) Analyst Ratings
Bulls say
UnitedHealth Group's robust growth is underscored by an anticipated 13% earnings increase in 2026, primarily driven by margin improvements within its Medicare and commercial segments. The Optum division demonstrates strong performance, with Optum Health projected to achieve earnings growth of approximately 9% and expanding margins, which contribute significantly to the company's overall earnings mix. Additionally, UnitedHealth's vertical integration strategy enhances its competitive positioning, as the Optum business effectively complements its core managed care operations, further solidifying its market leadership.
Bears say
UnitedHealth Group is facing a challenging outlook due to projected membership declines across its commercial risk and Medicare Advantage segments, with anticipated losses of 1.3 to 1.4 million members for 2026, significantly impacting revenue and market share. Additionally, the company's Medicaid margins are expected to deteriorate sharply, from a slim profit margin in 2025 to a projected loss of 1.8% in 2026, attributed to job-related Medicaid termination effects and industry-wide pressures on pricing structures. Moreover, the recent announcement of a minimal increase of 0.09% in MA rates for FY2027 contrasts sharply with expectations for mid-single-digit increases, reflecting ongoing regulatory pressure and a potentially unfavorable landscape for future earnings.
This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.
UnitedHealth Group (UNH) Analyst Forecast & Price Prediction
Start investing in UnitedHealth Group (UNH)
Order type
Buy in
Order amount
Est. shares
0 shares